C07J 41/0055
The 17-beta position being substituted by an uninterrupted chain of at least
Official title: {the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives}
C07J41/0055 (The 17-beta position being substituted by an uninterrupted chain of at least) appears on 510 US grants and 487 published applications in this corpus.
Search patents in C07J- Granted patents
- 510
- Published applications
- 487
- Assignees
- 328
- Inventors
- 1,184
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 6 | 0 |
| 1978 | 8 | 0 |
| 1979 | 5 | 0 |
| 1980 | 10 | 0 |
| 1981 | 8 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 6 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 6 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 13 | 0 |
| 1996 | 15 | 0 |
| 1997 | 19 | 0 |
| 1998 | 19 | 0 |
| 1999 | 12 | 0 |
| 2000 | 16 | 0 |
| 2001 | 9 | 1 |
| 2002 | 15 | 16 |
| 2003 | 5 | 13 |
| 2004 | 9 | 12 |
| 2005 | 3 | 12 |
| 2006 | 5 | 3 |
| 2007 | 4 | 7 |
| 2008 | 3 | 5 |
| 2009 | 8 | 5 |
| 2010 | 8 | 10 |
| 2011 | 3 | 11 |
| 2012 | 3 | 17 |
| 2013 | 4 | 16 |
| 2014 | 9 | 21 |
| 2015 | 13 | 24 |
| 2016 | 18 | 39 |
| 2017 | 21 | 33 |
| 2018 | 16 | 30 |
| 2019 | 32 | 28 |
| 2020 | 31 | 38 |
| 2021 | 22 | 27 |
| 2022 | 17 | 32 |
| 2023 | 16 | 23 |
| 2024 | 17 | 25 |
| 2025 | 16 | 25 |
| 2026 | 5 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof6 Oct 2026US 12,753,204 B2Enanta Pharmaceuticals, Inc.
- Bile acid-GCPII inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (IBD)4 Aug 2026US 12,698,306 B2Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- Preparation method and use of modified hydrophobic excipient5 May 2026US 12,616,676 B2Zhejiang Zhida Pharmaceutical Co., Ltd.
- Neuroactive steroids and methods of use thereof5 May 2026US 12,617,814 B2Sage Therapeutics, Inc.
- Small molecule modulators of gut bacterial bile acid metabolism17 Mar 2026US 12,577,273 B2President and Fellows of Harvard College
- Spleen-targeted lipid nanoparticles1 Oct 2026US 2026/0294826 A1Beijing Jitai Pharmaceutical Technology Co., Ltd.
- Antipseudomonal fusidic acid compounds20 Aug 2026US 2026/0240869 A1The Board of Trustees of the University of Illinois
- Aminosteroids for the Treatment of a PTP1B Associated Disease20 Aug 2026US 2026/0242409 A1Depymed, Inc.
- Amino acid derivative, preparation method therefor, and pharmaceutical composition for treating hepatitis, comprising same13 Aug 2026US 2026/0234180 A1Prazertherapeutics Inc.
- Sterol-based cationic lipids with aromatic head groups6 Aug 2026US 2026/0226094 A1Sanofi
Most cited
By later US patents
- Method for delivering nucleic acids into cells278US 5,283,185 AMcMaster University · 1994
- Conjugates and compositions for cellular delivery194US 7,491,805 B2Sirna Therapeutics, Inc. · 2009
- Cationic amphiphile/DNA complexes149US 5,948,767 AGenzyme Corporation · 1999
- Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules134US 5,767,099 AGenzyme Corporation · 1998
- Lipid-based nitric oxide donors134US 6,780,849 B2SciMed Life Systems, Inc. · 2004